These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 18521482

  • 1. Biphasic insulin aspart 30 treatment improves glycemic control among patients with type 2 diabetes in Saudi Arabia and the Gulf region.
    Ayad NM, Fattah WA, Bakry H.
    Saudi Med J; 2008 Jun; 29(6):919-20. PubMed ID: 18521482
    [No Abstract] [Full Text] [Related]

  • 2. Therapy conversion to biphasic insulin aspart 30 improves long-term outcomes and reduces the costs of type 2 diabetes in Saudi Arabia.
    Ali M, White J, Lee CH, Palmer JL, Smith-Palmer J, Fakhoury W, Valentine WJ.
    J Med Econ; 2008 Jun; 11(4):651-70. PubMed ID: 19450074
    [Abstract] [Full Text] [Related]

  • 3. Differential lipid profile and hormonal response in type 2 diabetes by exogenous insulin aspart versus the insulin secretagogue repaglinide, at the same glycemic control.
    Chisalita SI, Lindström T, Eson Jennersjö P, Paulsson JF, Westermark GT, Olsson AG, Arnqvist HJ.
    Acta Diabetol; 2009 Mar; 46(1):35-42. PubMed ID: 18777156
    [Abstract] [Full Text] [Related]

  • 4. Insulin aspart: a review.
    Owens D, Vora J.
    Expert Opin Drug Metab Toxicol; 2006 Oct; 2(5):793-804. PubMed ID: 17014395
    [Abstract] [Full Text] [Related]

  • 5. Insulin therapy for maximal glycemic control in type 2 diabetes mellitus.
    Spellman CW.
    J Am Osteopath Assoc; 2007 Jul; 107(7):260-9. PubMed ID: 17682113
    [Abstract] [Full Text] [Related]

  • 6. Insulin analog lispro decreases insulin resistance and improves glycemic control in an obese patient with insulin-requiring type 2 diabetes.
    Darmon P, Curtillet C, Boullu S, Laugier A, Dutour A, Oliver C.
    Diabetes Care; 1998 Sep; 21(9):1575. PubMed ID: 9727917
    [No Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of colesevelam in patients with type 2 diabetes mellitus and inadequate glycemic control receiving insulin-based therapy.
    Goldberg RB, Fonseca VA, Truitt KE, Jones MR.
    Arch Intern Med; 2008 Jul 28; 168(14):1531-40. PubMed ID: 18663165
    [Abstract] [Full Text] [Related]

  • 8. A comparison of insulin aspart and regular insulin in elderly patients with type 2 diabetes.
    Meneilly GS.
    Diabetes Obes Metab; 2007 Sep 28; 9(5):754-5. PubMed ID: 17697065
    [Abstract] [Full Text] [Related]

  • 9. Clinical perspectives in type 2 diabetes care: optimizing glycemic control with insulin therapy.
    Diabetes Educ; 2005 Sep 28; Suppl():1-14; quiz 15-6. PubMed ID: 15786628
    [No Abstract] [Full Text] [Related]

  • 10. [Biphasic analog insulin instead of mixed insulin. Better adjustment, less hypoglycemia].
    MMW Fortschr Med; 2003 Jun 12; 145(24):56. PubMed ID: 12866308
    [No Abstract] [Full Text] [Related]

  • 11. Starting insulin therapy in type 2 diabetes: lesson 2.
    McCall AL.
    Curr Diab Rep; 2005 Oct 12; 5(5):326-8. PubMed ID: 16188165
    [No Abstract] [Full Text] [Related]

  • 12. Improved glycaemic control with BIAsp 30 in insulin-naïve type 2 diabetes patients inadequately controlled on oral antidiabetics: subgroup analysis from the IMPROVE study.
    Wenying Y, Benroubi M, Borzi V, Gumprecht J, Kawamori R, Shaban J, Shah S, Shestakova M, Ligthelm R, Valensi P, IMPROVE Study Group Expert Panel.
    Curr Med Res Opin; 2009 Nov 12; 25(11):2643-54. PubMed ID: 19751116
    [Abstract] [Full Text] [Related]

  • 13. Preoperative hypoglycemia in a patient receiving insulin detemir.
    Olson RP, Bethel MA, Lien L.
    Anesth Analg; 2009 Jun 12; 108(6):1836-8. PubMed ID: 19448209
    [Abstract] [Full Text] [Related]

  • 14. The evidence for achieving glycemic control with incretin mimetics.
    Drucker DJ.
    Diabetes Educ; 2006 Jun 12; 32 Suppl 2():72S-81S. PubMed ID: 16554431
    [No Abstract] [Full Text] [Related]

  • 15. Biphasic insulin treatment in type 2 diabetes patients.
    Pitocco D, Zaccardi F.
    Acta Biomed; 2010 Sep 12; 81(2):85-6. PubMed ID: 21309129
    [No Abstract] [Full Text] [Related]

  • 16. The rapid-acting properties of insulin aspart are preserved in elderly people with type 2 diabetes.
    Krones R, Schütte C, Heise T.
    Diabetes Obes Metab; 2009 Jan 12; 11(1):41-4. PubMed ID: 19120432
    [Abstract] [Full Text] [Related]

  • 17. Glycemic control for organs: a new approach to a controversial topic.
    Nunnally ME, O'Connor MF.
    Anesthesiology; 2009 Feb 12; 110(2):207-8. PubMed ID: 19194143
    [No Abstract] [Full Text] [Related]

  • 18. Exercise training improves glycemic control in long-standing insulin-treated type 2 diabetic patients.
    De Feyter HM, Praet SF, van den Broek NM, Kuipers H, Stehouwer CD, Nicolay K, Prompers JJ, van Loon LJ.
    Diabetes Care; 2007 Oct 12; 30(10):2511-3. PubMed ID: 17626892
    [No Abstract] [Full Text] [Related]

  • 19. Achieving glycemic goals in type 2 diabetes.
    Bloomgarden ZT.
    Diabetes Care; 2007 Jan 12; 30(1):174-80. PubMed ID: 17192357
    [No Abstract] [Full Text] [Related]

  • 20. Thrice-daily biphasic insulin aspart 30 may be another therapeutic option for Chinese patients with type 2 diabetes inadequately controlled with oral antidiabetic agents.
    Yang WY, Ji QH, Zhu DL, Yang JK, Chen LL, Liu ZM, Yu DM, Yan L.
    Chin Med J (Engl); 2009 Jul 20; 122(14):1704-8. PubMed ID: 19719975
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.